JPH09511254A - エアゾル化のための新規および改良されたアミノグリコシド処方物 - Google Patents
エアゾル化のための新規および改良されたアミノグリコシド処方物Info
- Publication number
- JPH09511254A JPH09511254A JP8513968A JP51396896A JPH09511254A JP H09511254 A JPH09511254 A JP H09511254A JP 8513968 A JP8513968 A JP 8513968A JP 51396896 A JP51396896 A JP 51396896A JP H09511254 A JPH09511254 A JP H09511254A
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- nebulizer
- tobramycin
- aerosol
- aminoglycoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.気管支内感染症を患う患者の気管支内腔で少なくとも95%の感受性細菌を抑 制および阻害するためのエアゾル処方物であって、 該処方物が、約0.225%の塩化ナトリウムを含有する約5mlの溶液に溶解する約 200mg〜約400mgのアミノグリコシドを含み; 該処方物が約5.5と6.5との間のpHを有し; 該処方物が、主に1μと5μとの間のエアゾル粒子サイズを生成し得るジェッ トまたは超音波ネブライザーを使用するエアゾル化により投与される、エアゾル 処方物。 2.前記pHが約6.0である、請求項1に記載のエアゾル。 3.前記ネブライザーがジェットネブライザーである、請求項2に記載のエアゾ ル。 4.前記ネブライザーが超音波ネブライザーである、請求項2に記載のエアゾル 。 5.Pseudomonas aeruginosa感染症を患う患者の気管支内腔における少なくとも 95%のPseudomonas aeruginosa細菌を抑制および阻害するためのエアゾル処方物 であって、 該処方物が0.225%の塩化ナトリウムを含有する約5mlの溶液に溶解する約300m gのトブラマイシンを含み; 該処方物が約5.5と6.5との間のpHを有し; 該処方物が、主に1μと5μとの間のエアゾル粒子サイズを生成し得るジェッ トまたは超音波ネブライザーを使用するエアゾル化により投与される、エアゾル 処方物。 6.前記pHが6.0である、請求項5に記載のエアゾル。 7.前記ネブライザーがジェットネブライザーである、請求項6に記載のエアゾ ル 8.前記ネブライザーが超音波ネブライザーである、請求項6に記載のエアゾル 。 9.Pseudomonas aeruginosa細菌の気管支内腔感染症の治療のための方法であっ て、該方法がこのような治療を必要とする患者に、0.225%の塩化ナトリウムを含 有する約5mlの溶液に溶解する約300mgのトブラマイシンを含むエアゾル処方物 を提供する工程によって行われ; 該処方物が約5.5と6.5との間のpHを有し; 該処方物が、主に1μと5μとの間のエアゾル粒子サイズを生成し得るジェッ トまたは超音波ネブライザーを使用するエアゾル化により投与される、方法。 10.前記エアゾル処方物のpHが約6.0である、請求項9に記載の方法。 11.前記エアゾル処方物の投与のために使用される前記ネブライザーがジェット ネブライザーである、請求項10に記載の方法。 12.前記エアゾル処方物の投与のために使用される前記ネブライザーが超音波ネ ブライザーである、請求項10に記載の方法。 13.Pseudomonas aeruginosa細菌の気管支内感染症の治療のための方法であっ て、該方法がこのような治療を必要とする患者に、0.225%の塩化ナトリウムを含 有する約5mlの溶液に溶解する約200〜約400mgのアミノグリコシドを含むエアゾ ル処方物を提供する工程によって行なわれ; 該処方物が約5.5と6.5との間のpHを有し; 該処方物が、主に1μと5μとの間のエアゾル粒子サイズを生成し得るジェッ トまたは超音波ネブライザーを使用するエアゾル化により投与される、方法。 14.前記エアゾル処方物のpHが約6.0である、請求項13に記載の方法。 15.前記エアゾル処方物の投与のために使用される前記ネブライザーがジェット ネブライザーである、請求項14に記載の方法。 16.前記エアゾル処方物の投与のために使用される前記ネブライザーが超音波ネ ブライザーである、請求項14に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/325,705 US5508269A (en) | 1994-10-19 | 1994-10-19 | Aminoglycoside formulation for aerosolization |
US08/325,705 | 1994-10-19 | ||
PCT/US1995/012972 WO1996012471A1 (en) | 1994-10-19 | 1995-10-17 | Novel and improved aminoglycoside formulation for aerosolization |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09511254A true JPH09511254A (ja) | 1997-11-11 |
JP3474195B2 JP3474195B2 (ja) | 2003-12-08 |
Family
ID=23269063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51396896A Expired - Lifetime JP3474195B2 (ja) | 1994-10-19 | 1995-10-17 | エアゾル化のための新規および改良されたアミノグリコシド処方物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5508269A (ja) |
EP (1) | EP0734249B3 (ja) |
JP (1) | JP3474195B2 (ja) |
AT (1) | ATE183080T1 (ja) |
AU (1) | AU688166B2 (ja) |
CA (1) | CA2179305C (ja) |
DE (1) | DE69511374T3 (ja) |
DK (1) | DK0734249T3 (ja) |
ES (1) | ES2136883T7 (ja) |
GR (1) | GR3031770T3 (ja) |
WO (1) | WO1996012471A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004516302A (ja) * | 2000-12-27 | 2004-06-03 | サルース ファーマ インコーポレイテッド | 肺細菌感染症の治療及び予防のための吸入可能なアズトレオナム |
JP2004534763A (ja) * | 2001-05-18 | 2004-11-18 | カイロン コーポレイション | アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物 |
JP2011087968A (ja) * | 2000-02-11 | 2011-05-06 | Respironics Respiratory Drug Delivery (Uk) Ltd | 薬剤投与システム |
JP2013530248A (ja) * | 2010-07-12 | 2013-07-25 | クセリア ファーマシューティカルズ エーピーエス | エアロゾル化によるトブラマイシンの投与による肺感染症の治療 |
US9345663B2 (en) | 2000-12-27 | 2016-05-24 | Gilead Sciences, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
JP2020534859A (ja) * | 2017-09-29 | 2020-12-03 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 緑膿菌による肺定着/感染の発現リスクを予測する方法 |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083922A (en) * | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
US6076520A (en) * | 1997-05-12 | 2000-06-20 | Cooper; Emily L. | Device for nasal therapeutic inhalation |
US20060165606A1 (en) * | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
TW465235B (en) | 1998-09-17 | 2001-11-21 | United Video Properties Inc | Electronic program guide with digital storage |
DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
EP1161247A4 (en) * | 1998-12-17 | 2002-05-15 | Chiron Corp | Treatment method for severe chronic bronchitis (bronchiectasis) using an antibiotic aerosol |
US6613352B2 (en) | 1999-04-13 | 2003-09-02 | Universite De Montreal | Low-rigidity liposomal formulation |
US20020061281A1 (en) * | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US6576224B1 (en) * | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
US8820316B2 (en) * | 2000-02-11 | 2014-09-02 | Respironics Respiratory Drug Delivery (Uk) Ltd | Drug delivery apparatus |
US8336545B2 (en) | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
US7971588B2 (en) * | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
DK1280520T4 (en) | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
EP1598059A1 (en) | 2001-05-18 | 2005-11-23 | Chiron Corporation | Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
SI1273292T1 (en) * | 2001-07-02 | 2004-12-31 | Chiesi Farmaceutici S.P.A. | Optimised formulation of tobramycin for aerosolization |
US20040022740A1 (en) * | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
EP1458360B1 (en) * | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonary delivery of aminoglycosides |
ME00077B (me) * | 2002-03-01 | 2010-06-10 | Chiesi Farm Spa | Formoterol najfiniji preparat |
US7607436B2 (en) * | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
US7334580B2 (en) * | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
WO2003101390A2 (en) * | 2002-05-31 | 2003-12-11 | Childrens Hospital And Regional Medical Center | Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function |
US6966649B2 (en) * | 2002-08-12 | 2005-11-22 | John H Shadduck | Adaptive optic lens system and method of use |
US20040045546A1 (en) * | 2002-09-05 | 2004-03-11 | Peirce Management, Llc | Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
DK1673074T3 (da) * | 2003-10-15 | 2007-05-07 | Pari Gmbh | Flydende præparat, indeholdende tobramycin |
PL2316419T3 (pl) * | 2004-05-17 | 2012-12-31 | Gilead Sciences Inc | Aerolizowana kombinacja fosfomycyna/tobramycyna do leczenia bakteryjnych infekcji dróg oddechowych |
PT1765288E (pt) * | 2004-06-18 | 2013-01-29 | Novartis Ag | Métodos de tratamento de infeções endobrônquicas |
US20060073173A1 (en) * | 2004-10-04 | 2006-04-06 | Maria Banach | Large-scale manufacturing process for the production of pharmaceutical compositions |
US8546423B2 (en) * | 2005-05-18 | 2013-10-01 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
AU2013206401B2 (en) * | 2005-09-29 | 2016-06-23 | Novartis Ag | Antibiotic formulations, unit doses, kits, and methods |
US20070116649A1 (en) * | 2005-09-29 | 2007-05-24 | Nektar Therapeutics | Antibiotic formulations, unit doses, kits, and methods |
PL1962805T3 (pl) | 2005-12-08 | 2017-01-31 | Insmed Incorporated | Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych |
WO2007070875A1 (en) * | 2005-12-15 | 2007-06-21 | Aerosol Science Laboratories, Inc. | Treatment of active infections and related compositions |
EP2012750B1 (en) * | 2006-04-06 | 2018-02-21 | Insmed Incorporated | Methods for coacervation induced liposomal encapsulation and formulations thereof |
EP2049139A4 (en) * | 2006-04-24 | 2009-06-24 | Gloucester Pharmaceuticals Inc | TREATMENT OF TUMORS EXPRESSING RAS |
US20070286818A1 (en) * | 2006-06-07 | 2007-12-13 | Wyeth | Treating cystic fibrosis with antibiotics via an aerosol drug |
US20070286817A1 (en) * | 2006-06-07 | 2007-12-13 | Wyeth | Treating cystic fibrosis with antibiotics via a swirler delivery |
WO2007145866A1 (en) * | 2006-06-07 | 2007-12-21 | Wyeth | Treating cystic fibrosis with antibiotics via a swirler delivery |
PE20080329A1 (es) * | 2006-06-07 | 2008-04-09 | Wyeth Corp | Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol |
US8957027B2 (en) | 2006-06-08 | 2015-02-17 | Celgene Corporation | Deacetylase inhibitor therapy |
US20080221132A1 (en) | 2006-09-11 | 2008-09-11 | Xiong Cai | Multi-Functional Small Molecules as Anti-Proliferative Agents |
AU2007297691B2 (en) * | 2006-09-19 | 2013-12-19 | Discovery Laboratories, Inc. | Pulmonary surfactant formulations and methods for promoting mucus clearance |
JP2008199905A (ja) * | 2007-02-16 | 2008-09-04 | Snow Brand Milk Prod Co Ltd | 乳酸菌生残性向上剤 |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
CN101873851A (zh) * | 2007-09-25 | 2010-10-27 | 诺瓦提斯公司 | 用气雾化药物如万古霉素治疗肺部疾病 |
MX2010012452A (es) * | 2008-05-15 | 2011-03-15 | Novartis Ag Star | Suministro pulmonar de una fluoro-quinolona. |
NO2344129T3 (ja) | 2008-10-07 | 2018-07-21 | ||
PT2346509T (pt) | 2008-10-07 | 2020-08-05 | Horizon Orphan Llc | Inalação de levofloxacina para redução da inflamação pulmonar |
BRPI1007836A2 (pt) | 2009-02-27 | 2015-09-01 | Enanta Phamaceuticals Inc | Inibidores do vírus c da hepatite |
EP2408425A1 (en) * | 2009-03-20 | 2012-01-25 | Livia Tiba | Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution |
EP3309151A1 (en) | 2009-06-25 | 2018-04-18 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
SI2473170T1 (sl) | 2009-09-04 | 2019-10-30 | Horizon Orphan Llc | Uporaba aerosoliziranega levofloksacina za zdravljenje cistične fibroze |
WO2011073002A1 (en) | 2009-12-14 | 2011-06-23 | Chiesi Farmaceutici S.P.A. | Antibiotic microparticles for inhalation |
CA2798172C (en) | 2010-01-07 | 2017-11-21 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
EP2388008A1 (en) | 2010-05-14 | 2011-11-23 | Combino Pharm, S.L. | Stable, preservative-free, aqueous formulation for the administration by aerosolization comprising tobramycin |
AU2011270701B2 (en) | 2010-06-24 | 2015-05-14 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
CA2822447C (en) | 2010-12-23 | 2018-05-01 | Alkermes Pharma Ireland Limited | Multi-api loading prodrugs |
TWI574687B (zh) | 2011-01-03 | 2017-03-21 | 古利斯股份有限公司 | 具有鋅結合部份之刺蝟拮抗劑 |
RS54903B1 (sr) | 2011-04-01 | 2016-10-31 | Curis Inc | Inhibitor fosfoinozitid 3 kinaze sa delom koji vezuje cink |
BR112014000275A2 (pt) | 2011-07-12 | 2017-04-18 | Cardeas Pharma Inc | formulações aperfeiçoadas de combinações de aminoglicosídeo e fosfomicina e métodos e sistemas para o tratamento de pneumonia associada à ventilação mecânica (pavm) e traqueobronquite associada à ventilação mecânica (vat) |
US8826904B2 (en) | 2011-07-12 | 2014-09-09 | Cardeas Pharma Corporation | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
PT2567691E (pt) | 2011-09-12 | 2015-04-09 | Pari Pharma Gmbh | Composições aquosas que compreendem arbecacina |
ES2715562T3 (es) | 2011-12-15 | 2019-06-04 | Alkermes Pharma Ireland Ltd | Profármacos de compuestos de amina secundaria |
CA2858808C (en) | 2011-12-15 | 2017-04-18 | Alkermes Pharma Ireland Limited | Samidorphan (alks 33) in combination with opioid agonists |
GB201208080D0 (en) | 2012-05-09 | 2012-06-20 | Norton Healthcare Ltd | Tobramycin formulation |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
CN102949379B (zh) * | 2012-11-14 | 2014-11-05 | 中山大学 | 硫酸奈替米星吸入粉雾剂及其制备方法 |
CA2891487A1 (en) | 2012-11-29 | 2014-06-05 | Insmed Incorporated | Stabilized vancomycin formulations |
US9771327B2 (en) | 2013-03-13 | 2017-09-26 | Flatley Discovery Lab, Llc | Compounds and methods for the treatment of cystic fibrosis |
DK3125936T3 (da) | 2014-03-31 | 2019-08-05 | Debiopharm Int Sa | Fgfr-fusioner |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
CN106794243A (zh) | 2014-08-26 | 2017-05-31 | 哈斯福制药公司 | 新型免疫剂及其使用方法 |
BR112017007072A2 (pt) | 2014-10-06 | 2018-01-30 | Flatley Discovery Lab Llc | compostos de triazolopiridina e métodos para o tratamento de fibrose cística |
WO2016089981A1 (en) * | 2014-12-04 | 2016-06-09 | Carefusion 2200, Inc. | Breath-actuated nebulizer for medicine inhalation |
CN105616345B (zh) * | 2016-03-01 | 2018-08-21 | 上海方予健康医药科技有限公司 | 一种妥布霉素吸入组合物及其制备方法和用途 |
ES2938341T3 (es) | 2016-03-07 | 2023-04-10 | Enanta Pharm Inc | Agentes antivirales contra la hepatitis B |
US11597708B2 (en) | 2016-09-16 | 2023-03-07 | Hsf Pharmaceuticals Sa | Inhibitors of heat shock factors and uses thereof |
WO2019170871A1 (en) | 2018-03-08 | 2019-09-12 | Hsf Pharmaceuticals | Localized activation of virus replication boosts herpesvirus-vectored vaccines |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
WO2019215207A1 (en) | 2018-05-10 | 2019-11-14 | Cis Pharma Ag | Biocompatible copolymer containing multiple active agent molecules |
EP3849554A4 (en) | 2018-09-11 | 2022-06-01 | Curis, Inc. | POLYTHERAPY WITH A PHOSPHOINONOSITIDE 3-KINASE INHIBITOR HAVING A ZINC-BINDING METAL |
US10865211B2 (en) | 2018-09-21 | 2020-12-15 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
EP3653716A1 (en) | 2018-11-19 | 2020-05-20 | HSF Pharmaceuticals | Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore |
GB2565941A (en) * | 2018-11-27 | 2019-02-27 | Norton Healthcare Ltd | A process for preparing a formulation |
CA3150503A1 (en) | 2019-10-30 | 2021-05-06 | Cis Pharma Ag | BIOCOMPATIBLE POLYMERIC MEDICATION CARRIES FOR THE DELIVERY OF ACTIVE AGENTS |
EP4138898A1 (en) | 2020-04-24 | 2023-03-01 | HSF Pharmaceuticals | Replication-competent controlled herpesviruses expressing a sars cov-2 antigen |
US20230233514A1 (en) | 2020-06-23 | 2023-07-27 | Flagship Pioneering, Inc. | Antiviral compounds and methods of using the same |
US20220033383A1 (en) | 2020-07-20 | 2022-02-03 | Enanta Pharmaceuticals, Inc. | Functionalized peptides as antiviral agents |
MX2023005984A (es) | 2020-11-23 | 2023-08-17 | Enanta Pharm Inc | Nuevos agentes antivirales derivados de la espiropirrolidina. |
WO2023006993A1 (en) | 2021-07-30 | 2023-02-02 | Atmosr | Fused amino pyridine or pyrimidine derivatives for the treatment of congenital central hypoventilation syndrome |
CN114177140A (zh) * | 2021-12-10 | 2022-03-15 | 卓和药业集团股份有限公司 | 一种硫酸奈替米星气雾剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4424216A (en) * | 1979-07-31 | 1984-01-03 | The Rockefeller University | Method for the reduction of mucin viscosity |
JPH01283225A (ja) * | 1988-05-10 | 1989-11-14 | Toyo Jozo Co Ltd | 牛呼吸器感染症治療用エアゾール製剤およびそれを用いる治療方法 |
US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
-
1994
- 1994-10-19 US US08/325,705 patent/US5508269A/en not_active Expired - Lifetime
-
1995
- 1995-10-17 EP EP95937397A patent/EP0734249B3/en not_active Expired - Lifetime
- 1995-10-17 WO PCT/US1995/012972 patent/WO1996012471A1/en active IP Right Grant
- 1995-10-17 DE DE69511374T patent/DE69511374T3/de not_active Expired - Lifetime
- 1995-10-17 ES ES95937397T patent/ES2136883T7/es active Active
- 1995-10-17 DK DK95937397T patent/DK0734249T3/da active
- 1995-10-17 AT AT95937397T patent/ATE183080T1/de active
- 1995-10-17 CA CA002179305A patent/CA2179305C/en not_active Expired - Lifetime
- 1995-10-17 JP JP51396896A patent/JP3474195B2/ja not_active Expired - Lifetime
- 1995-10-17 AU AU39522/95A patent/AU688166B2/en not_active Expired
-
1999
- 1999-11-05 GR GR990402861T patent/GR3031770T3/el unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011087968A (ja) * | 2000-02-11 | 2011-05-06 | Respironics Respiratory Drug Delivery (Uk) Ltd | 薬剤投与システム |
JP2004516302A (ja) * | 2000-12-27 | 2004-06-03 | サルース ファーマ インコーポレイテッド | 肺細菌感染症の治療及び予防のための吸入可能なアズトレオナム |
JP4646489B2 (ja) * | 2000-12-27 | 2011-03-09 | ギリアド サイエンシズ, インコーポレイテッド | 肺細菌感染症の治療及び予防のための吸入可能なアズトレオナム |
US9345663B2 (en) | 2000-12-27 | 2016-05-24 | Gilead Sciences, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
US9533000B2 (en) | 2000-12-27 | 2017-01-03 | Gilead Sciences, Inc. | Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
JP2004534763A (ja) * | 2001-05-18 | 2004-11-18 | カイロン コーポレイション | アミノグリコシド抗生物質の吸入投与のための方法および単位用量処方物 |
JP2013530248A (ja) * | 2010-07-12 | 2013-07-25 | クセリア ファーマシューティカルズ エーピーエス | エアロゾル化によるトブラマイシンの投与による肺感染症の治療 |
JP2020534859A (ja) * | 2017-09-29 | 2020-12-03 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 緑膿菌による肺定着/感染の発現リスクを予測する方法 |
Also Published As
Publication number | Publication date |
---|---|
EP0734249B1 (en) | 1999-08-11 |
JP3474195B2 (ja) | 2003-12-08 |
DE69511374T3 (de) | 2012-04-12 |
DE69511374D1 (de) | 1999-09-16 |
CA2179305A1 (en) | 1996-05-02 |
WO1996012471A1 (en) | 1996-05-02 |
DK0734249T3 (da) | 1999-12-06 |
AU3952295A (en) | 1996-05-15 |
ATE183080T1 (de) | 1999-08-15 |
CA2179305C (en) | 2000-10-31 |
EP0734249A4 (en) | 1997-09-10 |
US5508269A (en) | 1996-04-16 |
ES2136883T7 (es) | 2012-06-14 |
GR3031770T3 (en) | 2000-02-29 |
EP0734249A1 (en) | 1996-10-02 |
DE69511374T2 (de) | 2000-02-24 |
AU688166B2 (en) | 1998-03-05 |
EP0734249B3 (en) | 2011-12-21 |
ES2136883T3 (es) | 1999-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09511254A (ja) | エアゾル化のための新規および改良されたアミノグリコシド処方物 | |
US6083922A (en) | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis | |
US6576224B1 (en) | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis | |
AU2002361918B2 (en) | Aerosolized decongestants for the treatment of sinusitis | |
US8168598B2 (en) | Optimised formulation of tobramycin for aerosolization | |
CZ20012147A3 (cs) | Farmaceutický prostředek ve formě suchého práąku nebo rozpráąeného aerosolového prostředku pro léčení chronické bronchitidy | |
AU2002361918A1 (en) | Aerosolized decongestants for the treatment of sinusitis | |
AU2002319226A1 (en) | Optimised formulation of tobramycin for aerosolization | |
JPH02196716A (ja) | 薬学的溶液 | |
US7097852B1 (en) | Solution comprising sea water as expectorant and virucidal for the treatment of respiratory diseases and method to use and develop | |
CN114129705A (zh) | 一种多肽在预防和治疗肺炎的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070919 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080919 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080919 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090919 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100919 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100919 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110919 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120919 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130919 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130919 Year of fee payment: 10 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130919 Year of fee payment: 10 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130919 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130919 Year of fee payment: 10 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130919 Year of fee payment: 10 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |